These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 20147581)

  • 41. Managing osteoporosis with FRAX® in Australia: proposed new treatment thresholds from the 45&Up Study cohort.
    Chen JS; Simpson JM; Blyth FM; March LM
    Bone; 2014 Dec; 69():148-53. PubMed ID: 25263521
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative randomized trial.
    Cauley JA; Robbins J; Chen Z; Cummings SR; Jackson RD; LaCroix AZ; LeBoff M; Lewis CE; McGowan J; Neuner J; Pettinger M; Stefanick ML; Wactawski-Wende J; Watts NB;
    JAMA; 2003 Oct; 290(13):1729-38. PubMed ID: 14519707
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Bone health management in prostate cancer patients receiving androgen deprivation therapy.
    Dhanapal V; Reeves DJ
    J Oncol Pharm Pract; 2012 Mar; 18(1):84-90. PubMed ID: 21807761
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A prospective clinical practice intervention to improve osteoporosis management following distal forearm fracture.
    Cuddihy MT; Amadio PC; Gabriel SE; Pankratz VS; Kurland RL; Melton LJ
    Osteoporos Int; 2004 Sep; 15(9):695-700. PubMed ID: 15007544
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group.
    McClung MR; Geusens P; Miller PD; Zippel H; Bensen WG; Roux C; Adami S; Fogelman I; Diamond T; Eastell R; Meunier PJ; Reginster JY;
    N Engl J Med; 2001 Feb; 344(5):333-40. PubMed ID: 11172164
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Fracture burden in relation to low bone mineral density and FRAX(®) probability.
    Leslie WD; Morin S
    J Clin Densitom; 2011; 14(3):279-85. PubMed ID: 21723761
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dietary protein intake and risk of osteoporotic hip fracture in elderly residents of Utah.
    Wengreen HJ; Munger RG; West NA; Cutler DR; Corcoran CD; Zhang J; Sassano NE
    J Bone Miner Res; 2004 Apr; 19(4):537-45. PubMed ID: 15005839
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Missing a therapeutic window of opportunity: an audit of patients attending a tertiary teaching hospital with potentially osteoporotic hip and wrist fractures.
    Smith MD; Ross W; Ahern MJ
    J Rheumatol; 2001 Nov; 28(11):2504-8. PubMed ID: 11708425
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Bone mineral density thresholds for pharmacological intervention to prevent fractures.
    Siris ES; Chen YT; Abbott TA; Barrett-Connor E; Miller PD; Wehren LE; Berger ML
    Arch Intern Med; 2004 May; 164(10):1108-12. PubMed ID: 15159268
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evaluation of the FRAX and Garvan fracture risk calculators in older women.
    Bolland MJ; Siu AT; Mason BH; Horne AM; Ames RW; Grey AB; Gamble GD; Reid IR
    J Bone Miner Res; 2011 Feb; 26(2):420-7. PubMed ID: 20721930
    [TBL] [Abstract][Full Text] [Related]  

  • 51. High-trauma fractures and low bone mineral density in older women and men.
    Mackey DC; Lui LY; Cawthon PM; Bauer DC; Nevitt MC; Cauley JA; Hillier TA; Lewis CE; Barrett-Connor E; Cummings SR;
    JAMA; 2007 Nov; 298(20):2381-8. PubMed ID: 18042915
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hip fracture risk in older US adults by treatment eligibility status based on new National Osteoporosis Foundation guidance.
    Looker AC; Dawson-Hughes B; Tosteson AN; Johansson H; Kanis JA; Melton LJ
    Osteoporos Int; 2011 Feb; 22(2):541-9. PubMed ID: 20480142
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Use of FRAX as a determinant for risk-based osteoporosis screening may decrease unnecessary testing while improving the odds of identifying treatment candidates.
    Edwards FD; Grover ML; Cook CB; Chang YH
    Womens Health Issues; 2014; 24(6):629-34. PubMed ID: 25128036
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Enhancement of hip fracture healing in the elderly: Evidence deriving from a pilot randomized trial.
    Kanakaris NK; West RM; Giannoudis PV
    Injury; 2015 Aug; 46(8):1425-8. PubMed ID: 26175420
    [TBL] [Abstract][Full Text] [Related]  

  • 55. An assessment of intervention thresholds for very high fracture risk applied to the NOGG guidelines : A report for the National Osteoporosis Guideline Group (NOGG).
    Kanis JA; Johansson H; Harvey NC; Lorentzon M; Liu E; Vandenput L; McCloskey EV
    Osteoporos Int; 2021 Oct; 32(10):1951-1960. PubMed ID: 33813622
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The care gap in diagnosis and treatment of women with a fragility fracture.
    Bessette L; Ste-Marie LG; Jean S; Davison KS; Beaulieu M; Baranci M; Bessant J; Brown JP
    Osteoporos Int; 2008 Jan; 19(1):79-86. PubMed ID: 17641811
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Osteoporosis-Related Health Services Utilization Following First Hip Fracture Among a Cohort of Privately-Insured Women in the United States, 2008-2014: An Observational Study.
    Gillespie CW; Morin PE
    J Bone Miner Res; 2017 May; 32(5):1052-1061. PubMed ID: 28229485
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical decision support system for the management of osteoporosis compared to NOGG guidelines and an osteology specialist: a validation pilot study.
    Gudmundsson HT; Hansen KE; Halldorsson BV; Ludviksson BR; Gudbjornsson B
    BMC Med Inform Decis Mak; 2019 Feb; 19(1):27. PubMed ID: 30709348
    [TBL] [Abstract][Full Text] [Related]  

  • 59. How well are community-living women treated for osteoporosis after hip fracture?
    Bellantonio S; Fortinsky R; Prestwood K
    J Am Geriatr Soc; 2001 Sep; 49(9):1197-204. PubMed ID: 11559379
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Patterns of Pharmacological Treatment for Osteoporosis Among Patients Qualified for Pharmacotherapy According to the National Osteoporosis Foundation Guidelines.
    Wang CC; Wu CH; Farley JF
    Ann Pharmacother; 2015 Sep; 49(9):995-1003. PubMed ID: 26041809
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.